Cargando…
Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerg...
Autores principales: | Mangan, Patricia, Stadtmauer, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857331/ https://www.ncbi.nlm.nih.gov/pubmed/33598318 http://dx.doi.org/10.6004/jadpro.2020.11.3.5 |
Ejemplares similares
-
Guidelines for Keeping Pace with Innovation and Tech Adoption
por: Schindler, Esther
Publicado: (2016) -
CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
por: Stadtmauer, Edward, et al.
Publicado: (2017) -
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
por: Antunes, Ana, et al.
Publicado: (2023) -
Implantable Cardiac Pacing Devices Related Complications: Keeping Pace With Time
por: Bohora, Shomu
Publicado: (2011) -
Keeping Pace with the History of Evolving Runtime Models
por: Sakizloglou, Lucas, et al.
Publicado: (2021)